The aphasia community hopes Bruce Willis’ diagnosis will help reduce the stigma of invisible illnesses and lead to better understanding of a condition that affects about 2 million Americans.
Emily Baumgaertner
Posted inCOVID 2022
Car crash deaths have surged during COVID-19 pandemic. Here’s why
Evidence suggests the pandemic has made U.S. drivers more reckless — more likely to speed, drink or use drugs and to leave their seatbelts unbuckled.
Posted inHealth & Wellness
It’s the first holiday season with COVID vaccines and boosters. But case rates are climbing
“I’m hopeful that it won’t be as bad as last winter — but it could still be really, really bad,” one infectious disease expert said. “The people we are least worried about are the ones seeking out the vaccines. We know that boosters can cut down a vaccinated person’s risk even more. But if that’s all we focus on, we are still leaving dangerous gaps in immunity.”
Posted inHealth & Wellness
How drug overdose deaths surpassed 100,000 in one year
Sam Quinones, author of ‘The Least of Us: True Tales of America and Hope in the Time of Fentanyl and Meth,’ on the horrific rise in overdose deaths.
Posted inEnvironment
Young climate activists warn their elders: Stop destroying the planet
Young activists are coming of age when the effects of the climate crisis are already being felt — foreshadowing a perilous future. They want the United Nations COP26 summit to reduce global warming.
Posted inVaccine Watch
Should wealthy nations forgo boosters until COVID vaccination improves worldwide? WHO says yes
Booster moratorium, or booster momentum? WHO chief’s call to ease vaccine disparity draws mixed response
Posted inVaccine Watch
CDC recommends Pfizer-BioNTech vaccine for children as young as 12
The recommendation means many middle schoolers and virtually all high school students have the chance to be vaccinated before the next school year.
Posted inVaccine Watch
Vaccine companies and the U.S. government snubbed WHO initiative to scale up global manufacturing
Last year the World Health Organization launched a program that aimed to scale up production of COVID-19 vaccines in Latin America, Asia and Africa. Pfizer and Moderna refused to participate.
Posted inVaccine Watch
A third COVID-19 vaccine could soon join the U.S. market. Will enough people want it?
The J&J vaccine didn’t appear to perform as well as others in clinical trials. But scientists say it is impossible to know whether any one vaccine is better.
Posted inCOVID Today
New clinical trials raise fears the coronavirus is learning how to resist vaccines
Researchers once believed it would take months or even years for the virus to develop resistance to vaccines. The speedy evolution is largely a result of the virus’ unchecked spread.